[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $cinc AstraZeneca's Baxdrostat trial met its endpoints, positively impacting CINC. The acquisition of CINC by AZN in January 2023 is now showing positive results. ### About $cinc CINC is likely a ticker symbol for a company involved in a recent acquisition by AstraZeneca. ### Engagements: XX [#](/topic/$cinc/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$cinc/time-series/interactions.tsv) **Current Value**: XX **Daily Average**: XXX **1 Month**: XXXXX +26,780% **1-Year High**: XXXXX on 2025-07-14 **1-Year Low**: X on 2025-06-24 | Social Network | X | | -------------- | - | | Engagements | X | ### Mentions: X [#](/topic/$cinc/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$cinc/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Month**: X +150% **1-Year High**: X on 2025-07-14 **1-Year Low**: X on 2025-06-07 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$cinc/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$cinc/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $cinc in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1 Month**: X +150% **1-Year High**: X on 2025-07-14 **1-Year Low**: X on 2025-06-07 **Top assets mentioned** In the posts about $cinc in the last XX hours [AstraZeneca PLC (AZN)](/topic/$azn) **Top topics mentioned** In the posts about $cinc in the last XX hours [manat](/topic/manat), [$azn](/topic/$azn), [stocks healthcare](/topic/stocks-healthcare), [stocks](/topic/stocks), [azn astrazeneca](/topic/azn-astrazeneca), [acquisition](/topic/acquisition) ### Top Social Posts [#](/topic/$cinc/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$CINC CVR looks in good shape after $AZN said baxdrostat Phase X trial was succesful. The CVR will pay $XX if/when an NDA is submitted" [@Avaritia2011](/creator/x/Avaritia2011) on [X](/post/tweet/1944731038573359314) 2025-07-14 12:09:45 UTC XXX followers, XXX engagements "$AZN #Astrazeneca Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension. $CINC acquisition (January 2023) pays off" [@doepke_michel](/creator/x/doepke_michel) on [X](/post/tweet/1944714969359978990) 2025-07-14 11:05:54 UTC 4839 followers, XXX engagements "$AZN Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase X trial in patients with uncontrolled or treatment resistant hypertension. $CINC" [@BioStocks](/creator/x/BioStocks) on [X](/post/tweet/1944714144361386243) 2025-07-14 11:02:37 UTC 68.4K followers, 4082 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
AstraZeneca's Baxdrostat trial met its endpoints, positively impacting CINC. The acquisition of CINC by AZN in January 2023 is now showing positive results.
CINC is likely a ticker symbol for a company involved in a recent acquisition by AstraZeneca.
Engagements 24-Hour Chart Data
Current Value: XX
Daily Average: XXX
1 Month: XXXXX +26,780%
1-Year High: XXXXX on 2025-07-14
1-Year Low: X on 2025-06-24
Social Network | X |
---|---|
Engagements | X |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Month: X +150%
1-Year High: X on 2025-07-14
1-Year Low: X on 2025-06-07
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $cinc in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Month: X +150%
1-Year High: X on 2025-07-14
1-Year Low: X on 2025-06-07
Top assets mentioned In the posts about $cinc in the last XX hours
Top topics mentioned In the posts about $cinc in the last XX hours
manat, $azn, stocks healthcare, stocks, azn astrazeneca, acquisition
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$CINC CVR looks in good shape after $AZN said baxdrostat Phase X trial was succesful. The CVR will pay $XX if/when an NDA is submitted"
@Avaritia2011 on X 2025-07-14 12:09:45 UTC XXX followers, XXX engagements
"$AZN #Astrazeneca Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension. $CINC acquisition (January 2023) pays off"
@doepke_michel on X 2025-07-14 11:05:54 UTC 4839 followers, XXX engagements
"$AZN Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase X trial in patients with uncontrolled or treatment resistant hypertension. $CINC"
@BioStocks on X 2025-07-14 11:02:37 UTC 68.4K followers, 4082 engagements
/topic/$cinc